V
66
-2
GS
78
2
PH
77
3
ABT
50
3
GPC
58
-5
GME
65
3
AAL
32
-4
EIX
54
-4
ROK
46
3
MCD
62
10
AVY
77
2
EL
52
4
GPS
52
3
JCI
49
2
WM
85
-3
INTC
36
-5
AVB
62
-2
URBN
70
7
SIG
78
2
EW
38
-4
V
66
-2
GS
78
2
PH
77
3
ABT
50
3
GPC
58
-5
GME
65
3
AAL
32
-4
EIX
54
-4
ROK
46
3
MCD
62
10
AVY
77
2
EL
52
4
GPS
52
3
JCI
49
2
WM
85
-3
INTC
36
-5
AVB
62
-2
URBN
70
7
SIG
78
2
EW
38
-4
Financhill
Back

Vera Therapeutics Quote, Financials, Valuation and Earnings

The little-known AI stock you need to read about now...

Get the name - FREE.
Buy
63

VERA
Vera Therapeutics

Last Price:
41.42
Seasonality Move:
65.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Unlock the Secret to Earning Monthly Income!

Limited spots act swiftly

Vera Therapeutics Price Quote

$41.42
+1.77 (+4.46%)
(Updated: April 29, 2024 at 6:55 PM ET)

Vera Therapeutics Key Stats

Buy
63
Vera Therapeutics (VERA) is a Buy
Day range:
$38.40 - $40.25
52-week range:
$6.07 - $50.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
21.23%
Volume:
827.8K
Avg. volume:
1.1M
1-year change:
525.39%
Market cap:
$2.2B
Revenue:
$0
EPS:
$-2.29

How Much Does Vera Therapeutics Make?

Data Unavailable

Is Vera Therapeutics Growing As A Company?

Data Unavailable

Vera Therapeutics Stock Price Performance

  • Did Vera Therapeutics Stock Go Up Last Month?
    Vera Therapeutics share price went down by -4.64% last month
  • Did VERA's Share Price Rise Over The Last Year?
    VERA share price rose by 525.39% over the past 1 year

What Is Vera Therapeutics 52-Week High & Low?

Vera Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vera Therapeutics?

  • How Much Debt Does Vera Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Vera Therapeutics Have?
    Cash and short term investments quarterly total is $160.7M
  • What Is Vera Therapeutics’s Book Value Per Share?
    Book value per share is 2.29

Is Vera Therapeutics Cash Flow Positive?

  • What Is VERA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$92.2M
  • What Is Vera Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $133.5M
  • What Is Vera Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$39.4M

Vera Therapeutics Return On Invested Capital

Data Unavailable

Vera Therapeutics Earnings Date & Stock Price

Vera Therapeutics Competitors

  • Who Are Vera Therapeutics's Competitors?
    Below is a list of companies who compete with Vera Therapeutics or are related in some way:
    • Alpine Immune Sciences Inc (ALPN)
    • Checkpoint Therapeutics Inc (CKPT)
    • Fate Therapeutics Inc (FATE)
    • Mersana Therapeutics Inc (MRSN)
    • Vertex Pharmaceuticals Inc (VRTX)

Vera Therapeutics Dividend Yield

Data Unavailable

Vera Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -14.11%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 55.80
Upside from Last Price: 40.73%

Major Shareholders

  • How many VERA shares are owned by institutional investors?
    64.7M VERA shares are owned by institutional investors
  • How many VERA shares are owned by insiders?
    527.2K VERA shares are owned by insiders